http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_208c7c1c809c99337269fb9696e54115
Outgoing Links
Predicate | Object |
---|---|
family-name | Brown |
name | Gordon D Brown Gordon D. Brown |
given-name | Gordon D. Gordon D |
organization-name | Section of Infection and Immunity, Institute of Medical Sciences, University of Aberdeen, Aberdeen, United Kingdom Aberdeen Fungal Group, MRC Centre for Medical Mycology, Institute of Medical Sciences, University of Aberdeen, Aberdeen AB25 2ZD, U.K.; Medical Research Council Centre for Medical Mycology at the University of Exeter, Geoffrey Pope Building, Stocker Road, Exeter EX4 4QD, U.K. Immunity, Infection and Inflammation Programme Institute of Medical Sciences, University of Aberdeen Aberdeen UK *Aberdeen Fungal Group, Institute of Medical Sciences, University of Aberdeen, Aberdeen AB25 2ZD, United Kingdom; Institute of Infectious Disease and Molecular Medicine Faculty of Health Sciences University of Cape Town Observatory Cape Town South Africa; Aberdeen Fungal Group University of Aberdeen Institute of Medical Sciences Foresterhill Aberdeen UK Department of Health Management & Informatics, School of Medicine, University of Missouri-Columbia, Columbia, MO, USA MRC Centre for Medical Mycology University of Exeter Exeter UK Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen AB252ZD, UK.; MRC Centre for Medical Mycology, University of Exeter, Geoffrey Pope Building, Stocker Road, Exeter EX4 4QD, UK. Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. Aberdeen Fungal Group, University of Aberdeen, Aberdeen, United Kingdom MRC Centre for Medical Mycology, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, United Kingdom Institute of Infectious Disease and Molecular Medicine, Division of Immunology; Aberdeen Fungal Group, Section of Immunology and Infection, Division of Applied Medicine, Institute of Medical Sciences, Foresterhill, University of Aberdeen, Aberdeen AB25 2ZD, United Kingdom Department of Internal Medicine University of Wisconsin School of Medicine and Public Health University of Wisconsin‐Madison WI USA ¶Medical Research Council Centre for Medical Mycology Aberdeen Fungal Group, Institute of Medical Sciences, University of Aberdeen, Aberdeen AB25 2ZD, United Kingdom Aberdeen Fungal Group, Section of Immunology and Infection, Division of Applied Medicine, Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, United Kingdom; MRC Centre for Medical Mycology, University of Exeter, Exeter, UK. 4Sir William Dunn School of Pathology, University of Oxford, OX1 3RE Oxford, United Kingdom ¶Division of Immunology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Rondebosch, South Africa *Sir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom; Aberdeen Fungal Group, University of Aberdeen, Institute of Medical Sciences, Foresterhill, Aberdeen, United Kingdom Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, 7925, Cape Town, South Africa; Aberdeen Fungal Group, University of Aberdeen, Institute of Medical Sciences, Foresterhill, Aberdeen, AB25 2ZD, UK. Electronic address: gordon.brown@abdn.ac.uk. † Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa; and Medical Research Council Centre for Medical Mycology, University of Exeter, Exeter, EX4 4QD, UK. Gordon.Brown@exeter.ac.uk. Previous address: MRC Centre for Medical Mycology, University of Aberdeen, Aberdeen, AB25 2ZD, UK. Gordon.Brown@exeter.ac.uk. Division of Applied Medicine, University of Aberdeen, Aberdeen, United Kingdom Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory 7925, South Africa †Institute of Infectious Disease and Molecular Medicine, University of Cape Town, South Africa; and Sir William Dunn School of Pathology, Oxford University , United Kingdom #Section of Immunology and Infection, Division of Applied Medicine, Institute of Medical Sciences, University of Aberdeen, Aberdeen, United Kingdom Aberdeen Fungal Group, Section of Infection and Immunity, Institute of Medical Sciences, School of Medicine and Dentistry, University of Aberdeen, Aberdeen, United Kingdom; and MRC Centre for Medical Mycology, Aberdeen Fungal Group, School of Medicine, Medical Sciences & Nutrition, Institute of Medical Sciences, University of Aberdeen, Aberdeen, United Kingdom Aberdeen Fungal Group, Institute of Medical Sciences, University of Aberdeen, Aberdeen AB25 2ZD, UK. School of Medical Sciences, Institute of Medical Sciences, University of Aberdeen, Aberdeen AB25 2ZD, United Kingdom Aberdeen Fungal Group Institute of Medical Sciences Medical Research Council Centre for Medical Mycology at the University of Aberdeen Aberdeen UK Medical Research Council Centre for Medical Mycology, Institute of Medical Sciences, University of Aberdeen, Aberdeen, United Kingdom *Sir William Dunn School of Pathology, Oxford University, South Parks Road, Oxford, United Kingdom; and Aberdeen Fungal Group, MRC Centre for Medical Mycology, Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen, United Kingdom MRC Centre for Molecular and Cellular Biology, Department of Medical Biochemistry, University of Stellenbosch, Tygerberg, 7505,2South Africa Immunity Infection and Inflammation Programme Institute of Medical Sciences University of Aberdeen Aberdeen UK Centre for Biomedical Research, University of Victoria, Victoria 5Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town 7925, South Africa Medical Research Council Centre for Medical Mycology at the University of Aberdeen, Aberdeen Fungal Group, Institute of Medical Sciences, Foresterhill, Aberdeen AB25 2ZD, UK. MRC Centre for Medical Mycology at University of Exeter, Geoffrey Pope Building, Stocker Road, Exeter, UK. Gordon.brown@exeter.ac.uk. Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Rondebosch, South Africa Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Observatory, 7925, Cape Town, South Africa. *Institute of Infectious Disease and Molecular Medicine, Clinical Laboratory Sciences, Division of Immunology, University of Cape Town, Cape Town, South Africa, ‡Aberdeen Fungal Group, Division of Applied Medicine, Immunity, Infection and Inflammation Programme, University of Aberdeen, Aberdeen AB25 2ZD, United Kingdom; and Medical Research Council Centre for Medical Mycology at the University of Exeter, Geoffrey Pope Building, Stocker Road, EX4 4QD, Exeter, UK. Gordon.Brown@exeter.ac.uk. AFGrica Medical Mycology Research Unit, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, South Africa; MRC Centre for Medical Mycology at the University of Exeter, Geoffrey Pope Building, Stocker Road, Exeter, UK. Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, United Kingdom; Professor and Director, Health Services Management Program, University of Missouri — Columbia Section of Immunology and Infection, Division of Applied Medicine, Institute of Medical Sciences and The Aberdeen Fungal Group, University of Aberdeen, Aberdeen AB24 2ZD, UK. §Division of Immunology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa Aberdeen Fungal Group, Institute of Medical Sciences, Foresterhill, AB25 2ZD Aberdeen, United Kingdom;; Medical Research Council Centre for Medical Mycology, University of Exeter, EX4 4QD Exeter, United Kingdom; Section of Infection and ImmunityInstitute of Medical SciencesUniversity of AberdeenAberdeenUK Aberdeen Fungal Group, Institute of Medical Sciences, University of Aberdeen, Aberdeen AB25 2ZD, Scotland, UK 7 Gordon D. Brown is a professor at the Aberdeen Fungal Group, Institute of Medical Sciences, University of Aberdeen, AB25 2ZD, UK. Aberdeen Fungal Group, Section of Immunology and Infection, Division of Applied Medicine, Institute of Medical Sciences, University of Aberdeen, Aberdeen AB25 2ZD, UK *Sir William Dunn School of Pathology, Oxford University, Oxford, United Kingdom; and Aberdeen Fungal Group; University of Aberdeen; Institute of Medical Sciences; Foresterhill Aberdeen AB25 2ZD UK Institute of Medical Sciences University of Aberdeen Foresterhill Aberdeen UK Division of Immunology, CLS, Institute for Infectious Diseases and Molecular Medicine, University of Cape Town, 7925 Cape Town, South Africa 8 ‡Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa Medical Research Council Centre for Medical Mycology, University of Exeter Medical Research Council Centre for Medical Mycology at the University of Exeter Exeter UK Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, 7925, Cape Town, South Africa; MRC Centre for Medical Mycology, Aberdeen Fungal Group, University of Aberdeen, Institute of Medical Sciences, Foresterhill, Aberdeen AB25 2ZD, UK. §Section of Infection and Immunity, Institute of Medical Sciences, University of Aberdeen, Aberdeen AB25 2ZD, United Kingdom Medical Research Council Centre for Medical Mycology, University of Exeter, Exeter, United Kingdom 1Sir William Dunn School of Pathology, Oxford OX1 3RE, United Kingdom Institute for Infectious Diseases and Molecular Medicine, University of Cape Town , Cape Town , South Africa 1Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, United Kingdom Sir William Dunn School of Pathology , Oxford , United Kingdom Department of Health Management and Informatics, Center for Health Care Quality, School of Medicine, University of Missouri--Columbia, USA. |
Incoming Links
Total number of triples: 332.